Nissay Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$738K Buy
38,372
+1,445
+4% +$28.5K ﹤0.01% 605
2025
Q4
$699K Buy
36,927
+1,475
+4% +$27.3K ﹤0.01% 605
2025
Q3
$661K Hold
35,452
﹤0.01% 600
2025
Q2
$654K Buy
35,452
+351
+1% +$6.23K ﹤0.01% 634
2025
Q1
$613K Sell
35,101
-42
-0.1% -$708 ﹤0.01% 666
2024
Q4
$598K Buy
35,143
+567
+2% +$10.4K ﹤0.01% 683
2024
Q3
$643K Buy
34,576
+1,703
+5% +$28.7K ﹤0.01% 685
2024
Q2
$506K Buy
32,873
+2,257
+7% +$32.3K ﹤0.01% 694
2024
Q1
$452K Buy
30,616
+734
+2% +$10.2K ﹤0.01% 713
2023
Q4
$426K Buy
29,882
+1,334
+5% +$18.9K ﹤0.01% 694
2023
Q3
$398K Buy
28,548
+970
+4% +$12.4K ﹤0.01% 713
2023
Q2
$325K Buy
27,578
+2,136
+8% +$24.3K ﹤0.01% 726
2023
Q1
$293K Buy
25,442
+411
+2% +$5.08K ﹤0.01% 716
2022
Q4
$311K Buy
25,031
+144
+0.6% +$1.84K ﹤0.01% 709
2022
Q3
$327K Buy
24,887
+824
+3% +$12.2K ﹤0.01% 697
2022
Q2
$336K Sell
24,063
-1,209
-5% -$16.2K ﹤0.01% 705
2022
Q1
$376K Buy
25,272
+1,465
+6% +$20K ﹤0.01% 715
2021
Q4
$322K Buy
23,807
+2,624
+12% +$37.1K ﹤0.01% 731
2021
Q3
$312K Hold
21,183
﹤0.01% 728
2021
Q2
$386K Buy
21,183
+1,413
+7% +$25.2K ﹤0.01% 719
2021
Q1
$343K Buy
19,770
+2,277
+13% +$40K ﹤0.01% 702
2020
Q4
$304K Sell
17,493
-2,916
-14% -$46.5K ﹤0.01% 688
2020
Q3
$281K Buy
20,409
+1,019
+5% +$15K ﹤0.01% 693
2020
Q2
$280K Buy
19,390
+2,124
+12% +$27.9K 0.01% 693
2020
Q1
$189K Buy
17,266
+1,505
+10% +$27.8K ﹤0.01% 697
2019
Q4
$336K Buy
15,761
+535
+4% +$12K 0.01% 701
2019
Q3
$350K Hold
15,226
0.01% 695
2019
Q2
$300K Buy
15,226
+511
+3% +$9.96K 0.01% 711
2019
Q1
$287K Sell
14,715
-2,607
-15% -$49.4K 0.01% 692
2018
Q4
$285K Buy
17,322
+880
+5% +$17.7K 0.01% 680
2018
Q3
$380K Buy
16,442
+4,035
+33% +$91.4K 0.01% 667
2018
Q2
$270K Hold
12,407
0.01% 690
2018
Q1
$219K Buy
12,407
+1,463
+13% +$25.8K 0.01% 704
2017
Q4
$206K Buy
+10,944
New +$218K 0.01% 707

Other funds holding SBRA